Cancer Risk Panel - Advanced

Service Description

Includes all Basic panel markers, plus additional biomarkers linked to gastrointestinal and systemic malignancies. Basic biomarker: - Cancer Antigen 19-9 (CA 19-9) - Alpha-Fetoprotein (AFP) - Carcinoembryonic Antigen (CEA) - Cytokeratin-19 Fragment (CYFRA 21-1) - Neuron-Specific Enolase (NSE) Additional biomarkers - Cancer Antigen 242 - Cancer Antigen 72-4 - Ferritin - β2-Microglobulin Helps assess risk associated with: • Pancreatic cancer • Liver cancer • Lung cancer • Colorectal cancer • Neuroendocrine tumour • Gastric cancer • Multiple myeloma • Lymphoma and other malignancies Sample: BLOOD Results: 3 Days Phlebotomy fee: Included Note: Tumour markers are not diagnostic for cancer on their own. Elevated levels may also occur in non-cancerous conditions. Results should always be interpreted alongside clinical findings and appropriate imaging or diagnostic tests.